Galmed Pharmaceuticals Ltd. (EOCN) vs Jupiter Neurosciences, Inc. (JUNS)

Galmed Pharmaceuticals Ltd. and Jupiter Neurosciences, Inc. are both Biotechnology companies. Galmed Pharmaceuticals Ltd. and Jupiter Neurosciences, Inc. are of similar size ($3.8M and $3.8M). Across the 8 metrics below, Galmed Pharmaceuticals Ltd. leads on 6 and Jupiter Neurosciences, Inc. on 2.

Valuation

Metric EOCN JUNS Biotechnology median
P/E n/m n/m 7.88
P/S 1.70 n/m 11.47
P/B 0.27 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.54 n/m 0.74
EV/Sales (2.66) n/m 10.73
Earnings yield (418.18%) (716.02%) (28.84%)
Free cash flow yield (247.30%) (486.93%) (23.03%)

Profitability

Metric EOCN JUNS Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (68.21%) (1,888.80%) (57.72%)
Return on assets (55.03%) (239.36%) (49.22%)
Return on invested capital (163.19%) 0.00% 0.00%

Growth

Metric EOCN JUNS Biotechnology median
Revenue growth (TTM) 87.83% — 5.64%
EPS growth (last fiscal year) 70.42% (212.50%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric EOCN JUNS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.16 0.66 4.73
Net debt to EBITDA 1.31 0.43 0.96

Dividend

Metric EOCN JUNS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric EOCN JUNS Biotechnology median
Market cap 3.77m 3.80m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack